Data Further Examines SEROQUEL(R) (quetiapine fumarate) Treatment for Bipolar Depression (PR Newswire via Yahoo! Finance)

home   >   yahoo news

AstraZeneca today announced additional findings at the annual meeting of the American Psychiatric Association from the BOLDER trial, a large-scale study that examined SEROQUEL as a treatment for depressive episodes in patients with bipolar I and II disorders.

- link to Data Further Examines SEROQUEL(R) (quetiapine fumarate) Treatment for Bipolar Depression (PR Newswire via Yahoo! Finance) -
Last update: 05/26/2005

Recommended Reading

    Quetiapine promising for developmental disorders. (Children and Teens). : An article from: Clinical Psychiatry News
    Drug shortages challenge long-term patient care: Number of products affected up sharply. ('Domino Effect'). : An article from: Clinical Psychiatry News
    Developmental disorders respond to Quetiapine: moderate to high dose.(Behavioral Pediatrics) : An article from: Pediatric News
    Drug shortages challenge long-term patient care: Number of products affected up sharply. ('Domino Effect'). : An article from: Clinical Psychiatry News
    Seroquel shortage indicative of supply problems. (Sharp Increase in Drug Shortages). : An article from: Internal Medicine News
    Quetiapine promising for developmental disorders. (Children and Teens). : An article from: Clinical Psychiatry News
    Atypical Antipsychotics for Treating Depression.(Zyprexa, Risperdal, Seroquel, and Zeldox) : An article from: Behavioral Health Management
    Drug shortages challenge long-term patient care: Number of products affected up sharply. ('Domino Effect'). : An article from: Clinical Psychiatry News